StockGlow

Mankind Pharma Limited (MANKIND.NS)

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.

2,444.20-0.05%Healthcare
Compare MANKIND.NS with
StockGlow Score
65
Leaning Bullish
BearishBullish
1 year ago-4.7%

The outlook

Mankind Pharma Limited currently reads as leaning bullish based on buy — 2.3 avg of 19 analysts, mixed vs its moving averages, 70% of the way from its 52-week low to high, avg target +9% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusBuy — 2.3 avg of 19 analysts
Price trendMixed vs its moving averages
52-week range70% of the way from its 52-week low to high
Price targetAvg target +9% vs current price

Analyst price target

~12-month · 19 analysts
2,667.68average target+9.1% vs now
Now 2,444.20
Low 2,057.00High 3,100.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$1.01T
52-wk high
2,674.00
52-wk low
1,909.70
50-day avg
2,466.52
200-day avg
2,265.78
Trailing P/E
52.7

Similar stocks

ZYDUSLIFE.NSZydus Lifesciences Limited$1,121.60+0.58%MEDANTA.NSGlobal Health Limited$1,381.00-2.50%MAXHEALTH.NSMax Healthcare Institute Limited$1,117.10-0.68%PPLPHARMA.NSPiramal Pharma Limited$199.15+1.24%KAYNES.NSKaynes Technology India Limited$3,826.00+5.65%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy